Clinical Trial Update: Study of E6007 in Japanese Patients With Moderate Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of E6007 in Japanese patients with moderate active ulcerative colitis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• E6007

Snippet

Sponsor: EA Pharma Co., Ltd. | Conditions: Moderate Active Ulcerative Colitis | Phase 2 | Status: COMPLETED